Normal differentiation and malignant transformation of human cells are characterized by specific changes in surface antigen phenotype. In the present study, we have defined six cell-surface antigens of human sarcomas and normal mesenchymal cells, by using mixed hemadsorption assays and immunochemical methods for the analysis of cultured cells and immunohistochemical staining for the analysis of normal tissues and >200 tumor specimens. Differential patterns of F19 (Mr, 120,000/95,000 glycoprotein), F24 (Mr, 95,000 glycoprotein), G171 (Mr, 75,000 glycoprotein), G253 (Mr, 90,000 glycoprotein), S5 (Mr, 120,000 glycoprotein), and Thy-1 (Mr, 25,000 glycoprotein) antigen expression were found to characterize (i) subsets of cultured sarcoma cell lines, (i) cultured fibroblasts derived from various organs, (ii) normal resting and activated mesenchymal tissues, and (iv) sarcoma and nonmesenchymal tumor tissues. These results provide a basic surface antigenic map for cultured mesenchymal cells and mesenchymal tissues and permit the classification of human sarcomas according to their antigenic phenotypes. mAbs F19, F24, G253, S5, and K117 have been described (7, 9, 10). Mixed hemadsorption rosetting assays for detection of antigens on cultured cells were carried out as described (10).
mAbs F19, F24, G253, S5, and K117 have been described (7, 9, 10) . Mixed hemadsorption rosetting assays for detection of antigens on cultured cells were carried out as described (10) .
Immunohistochemical Procedures. Tissues were obtained at autopsy or from surgical specimens and quick-frozen as described (11) or, for some experiments with mAb K117, paraffin-embedded by the AMeX method (12); 5 pkm-sections were cut, mounted on gelatin-coated slides, air-dried, and fixed in cold acetone. The avidin-biotin immunoperoxidase and indirect immunofluorescence procedures were carried out as described (11, 13 experiments, followed by NaDodSO4/polyacrylamide gel electrophoresis and fluorography, as described (4) .
Distinct pathways and stages of cellular differentiation are associated with specific patterns of cell-surface antigen expression. This principle was first established through analysis of normal and malignant cells of hematopoietic origin and has been extended to the neuroectodermal lineage (1) (2) (3) (4) (5) (6) (7) . The identification of an ordered progression of surface phenotypic changes during normal differentiation has permitted classification of leukemias and lymphomas, melanomas, astrocytomas, and neuroblastomas into subsets that show antigenic similarity to normal cells at distinct stages of hematopoietic or neuroectodermal differentiation (2-4, 6, 7 (4, 8) were from the cell bank at Sloan-Kettering Institute.
Antibodies and Serological Procedures. Monoclonal antibody (mAb) G171 (IgG2a) was derived from a mouse immunized with human SK-GS-1 tumor cells as described (7) . (Figs. 1 and 2) ; fibroblasts from other normal tissues (skin, kidney, colon, and bone) were consistently G171 -, independent of the passage levels tested (range: primary culture to >15 passages). In normal adult tissues, G171 antigen was restricted to very few cell types (Table 1) , including capillary endothelium and endocrine cells in the adrenal medulla. In the fetus, G171 was expressed in some additional mesenchymal tissues, such as skeletal muscle and cartilage. Fetal perichondrium and renal capsule are G171-, but fetal fibroblasts located at epithelial-mesenchymal junctions in skin (Fig.  3E) , kidney, lung, and colon were G171 .
RESULTS
Among the >200 tumors tested by immunohistochemical procedures, G171 was expressed in a large proportion of sarcomas and in meningiomas as well as subsets of Schwannomas, lung and ovarian cancers, and teratocarcinomas ( (Figs. 1 and 2 ). Immunohistochemical analysis (Tables 1 and 2) showed that S5 antigen expression in vivo was much more restricted than was suggested by the wide distribution among cultured cells. In normal adult tissues, only visceral smooth muscle cells were strong S5 expressors (Fig. 3A) ; fibromuscular stroma of prostate and cervix showed weaker S5 immunoreactivity and vascular smooth muscle, cardiac, and skeletal muscle were S5 - (Fig.  3B ). In the fetus, both visceral smooth muscle and skeletal muscle were S5 + (Fig. 3C) , but all other cell types tested were S5 -. S5 expression in tumor tissues was restricted to a subset of leiomyosarcomas that generally showed weaker immunoreactivity than normal visceral smooth muscle. G253 Glycoprotein. mAb G253 defines a Mr 90,000 glycoprotein (gp90 or the G253 antigen) expressed on cultured sarcomas and SV40-transformed fibroblasts but not, or only weakly, on cultured normal fibroblasts ( Figs. 1 and 2 ). These results suggested that G253 antigen was a transformationspecific marker of mesenchymal cells, and we used immunohistochemical procedures to test 40 sarcomas for G253 expression. However, none of the tumor tissues showed antigen expression. In contrast, G253 was readily detected in normal vascular and visceral smooth muscle and in kidney glomeruli (Fig, 4A) , demonstrating that lack of G253 reactivity with sarcoma tissues was not due to failure of the mAb to detect antigen ip acetone-fixed frozen tissue sections.
Thy-i. mAb K117 recognizes human Thy-1 (10), a Mr 25,000 glycoprotein (gp25) expressed on cultured fibroblasts and sarcomas (Fig. 1) . Immunohistochemical analysis showed Thy-1 expression in a variety of cell types (Table 1) , including fibroblasts, muscularis mucosae of the gastrointestinal tract, fibromuscular stroma of prostate and cervix, connective tissue fibers (but not lymphoid ce!ls) in spleen and lymph nodes (Fig. 3F) , and specific portions of the renal tubules (Fig. 4B) cardiac muscle were Thy-1 -in the adult. Thy-1 expression in the fetus paralleled the adult pattern with two exceptions: basal keratinocytes of the skin and renal glomeruli expressed Thy-1 in the fetus but were Thy-1 -in the adult. Contrary to previous suggestions (14) , we did not find any Thy-1 expression in fetal skeletal muscle. Thy-1 expression in tumor tissues (Table 2 ) mirrored its distribution in normal tissues: Most sarcomas and neuroectodermal tumors (Fig. 5 G and   H) were Thy-i+, whereas most carcinomas were Thy-i-.
Notable exceptions were the presence of Thy-1 in a proportion of ovarian carcinomas, the absence of Thy-1 from melanomas [consistent with the Thy-1-phenotype of most cultured melanoma cell lines (9)], and the lack of Thy-1 expression in Ewing sarcomas, embryonal rhabdomyosarcomas, and mesenchymal chondrosarcomas (Fig. 5F ), a group of tumors distinguished by their "small round cell" phenotype.
DISCUSSION
Mesenchymal tissues comprise a range of cell types that differ in embryological derivation, morphology, and function. At (7), but the corresponding fresh tumor tissues are antigen-negative. Furthermore, cultured cells derived from fibrosarcomas are G171 -, whereas the corresponding tumor tissues are generally G171 . Parallel analysis of tumor specimens and derived cell lines will help determine at which stage changes in antigenic phenotype occur.
The G253 and S5 antigens also exhibit various patterns of expression in tissues and in cultured cell panels. G253 appears to be a marker of transformed mesenchymal cells in vitro. It is strongly expressed in most sarcoma cell lines and in SV40-transformed fibroblasts but was not found in any uncultured -sarcomas tested by immunohistochemical methods. S5 is expressed on a wide range of cultured mesenchymal and neuroectodermal cells, as well as on some cultured epithelial and hematopoietic cells (7), but in normal adult tissues the antigen is restricted to visceral smooth muscle. Moreover, among tumors tested by immunohistochemical; methods, S5 is restricted to leiomyosarcomas. Analysis of normal fetal tissues reveals that additional cell types express S5 transiently during development (e.g., skeletal muscle). It is thus conceivable that the wide distribution of S5 and G253 on cultured cells reflects specific activation of early developmental traits in the cultures or adaptive changes induced by altered cell-substrate or cell-cell interactions in cells grown on plastic culture surfaces. Since uncultured sarcomas and reactive mesenchyme do not generally express G253 or S5, it is less likely that they are linked to proliferation, as was suggested for F19.
The Thy-1 antigen was first identified as a thymocyte differentiation antigen in mice but has subsequently been found in lymphoid and neural tissues of several species, including humans (15 normal tissues. With respect to mesenchymal tissues, we found that subsets of normal cells can be distinguished by their Thy-1 phenotypes (e.g., visceral and vascular smooth muscle in various sites differ in antigen expression) and that sarcomas are generally Thy-1 +, except for those with "small round cell" phenotype (Ewing sarcoma, embryonal rhabdomyosarcoma, and mesenchymal chondrosarcoma).
Detailed analysis (cultured cell map, normal tissue map, and tumor tissue map) of six distinct human cell surface glycoproteins has revealed characteristic patterns of antigen expression in normal'developing and adult mesenchyme and in mesenchymal tumors. It is apparent that typing with mAbs F19, G71, S5, and K117 identifies subsets of sarcomas with distinctive antigenic phenotypes, and it is possible that these antigenic patterns correlate with differences in histogenesis or biological behavior. We have shown (16) that differential expression of the cell surface receptor for nerve growth factor also distinguishes subsets of human sarcomas, but in contrast to the glycoproteins described here, the receptor for nerve growth factor is selectively expressed in Ewing sarcomas and embryonal rhabdomyosarcomas. Since expression of F19, G171, and S5 is highly restricted in normal tissues, they may be useful targets for immunolocalization or immunotherapy of antigen-expressing tumors.
